First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.

[1]  F. Cavalli,et al.  Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Chan,et al.  Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Piccart,et al.  Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview. , 1997, European journal of cancer.

[4]  A. Hoque,et al.  Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Charnsangavej,et al.  Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Furuse,et al.  A phase II study of cisplatin in patients with biliary tract carcinoma. , 1994, Oncology.

[7]  S. Pyrhönen,et al.  Epirubicin‐Sequential Methotrexate‐5‐Fluorouracil‐Leucovorin Treatment in Advanced Cancer of the Extrahepatic Biliary System: A Phase II Study , 1994, American journal of clinical oncology.

[8]  R. Audisio,et al.  Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  P. Johnson,et al.  Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma , 1991, Cancer.

[10]  P. Schein,et al.  5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Moertel,et al.  Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer , 1984, Cancer.

[12]  G. Ramírez,et al.  Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy , 1974, Cancer.

[13]  F. Fossella.  Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer. , 1999, Seminars in oncology.

[14]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.